Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity
Authors
Keywords
-
Journal
NANO LETTERS
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2022-08-11
DOI
10.1021/acs.nanolett.2c01863
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells
- (2021) Jun Yan et al. CANCER LETTERS
- Drug Delivery with Polymeric Nanocarriers—Cellular Uptake Mechanisms
- (2020) Levi Collin Nelemans et al. Materials
- Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front
- (2020) Christian M. Schürch et al. CELL
- Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
- (2020) Astrid De Boeck et al. Nature Communications
- Roles of IFN-γ in tumor progression and regression: a review
- (2020) Dragica Jorgovanovic et al. Biomarker Research
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Importance of GFAP isoform-specific analyses in astrocytoma
- (2019) Emma J. van Bodegraven et al. GLIA
- Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma
- (2019) Zhilan Chai et al. ACS Nano
- Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
- (2019) Anna Galstyan et al. Nature Communications
- A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
- (2019) Zhichen Sun et al. Nature Communications
- Cell Membrane Coating Nanotechnology
- (2018) Ronnie H. Fang et al. ADVANCED MATERIALS
- Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death
- (2018) Tsadik Habtetsion et al. Cell Metabolism
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy
- (2018) Yu Zhang et al. NANO LETTERS
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
- (2018) Jun Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
- (2018) Jiawen Qian et al. Journal of Neuroinflammation
- Single tumor-initiating cells evade immune clearance by recruiting type II macrophages
- (2017) Xiaocan Guo et al. GENES & DEVELOPMENT
- Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1
- (2017) Hui Li et al. HEPATOLOGY
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- Cell membrane coated nanoparticles: next-generation therapeutics
- (2017) Ashwin Narain et al. Nanomedicine
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
- (2017) Yu Shi et al. Nature Communications
- Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
- (2017) Takuro Noguchi et al. Cancer Immunology Research
- Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse
- (2016) Tadashi Ashizawa et al. CLINICAL CANCER RESEARCH
- From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
- (2016) William A. Banks NATURE REVIEWS DRUG DISCOVERY
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
- (2016) D. Mathios et al. Science Translational Medicine
- Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
- (2015) Ryan M. Williams et al. NANO LETTERS
- Rapamycin: One Drug, Many Effects
- (2014) Jing Li et al. Cell Metabolism
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
- (2010) Janka Held-Feindt et al. EXPERIMENTAL CELL RESEARCH
- Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells
- (2009) Hae-Yun Cho et al. IMMUNOLOGY LETTERS
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
- (2009) X. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation